首页> 外国专利> PROGNOSTIC SIGNATURE FOR ORAL SQUAMOUS CELL CARCINOMA

PROGNOSTIC SIGNATURE FOR ORAL SQUAMOUS CELL CARCINOMA

机译:口腔鳞状细胞癌的预后标志

摘要

The present disclosure describes methods and compositions for diagnosing or predicting likelihood of a OSCC recurrence in a subject having undergone OSCC resection comprising: a) determining an expression level of one or more biomarkers selected from Table 4, 5 and/or 7, optionally MMP1, COL4A1, THBS2 and/or P4HA2 in a test sample from the subject, the one or more biomarkers comprising at least one of THBS2 and P4HA2, and b) comparing the expression level of the one or more biomarkers with a control, wherein a difference or a similarity in the expression level of the one or more biomarkers between the test sample and the control is used to diagnose or predict the likelihood of OSCC recurrence in the subject In particular, the present disclosure describes methods and compositions using a four-gene biomarker signature that can predict recurrence of oral squamous cell carcinoma in subjects that have histologically normal surgical resection margins.
机译:本公开描述了用于诊断或预测已经历OSCC切除的受试者中OSCC复发的可能性的方法和组合物,其包括:a)确定选自表4、5和/或7的一种或多种生物标志物的表达水平,任选地,MMP1,来自受试者的测试样品中的COL4A1,THBS2和/或P4HA2,所述一种或多种生物标记物包含THBS2和P4HA2中的至少一种,并且b)将一种或多种生物标记物的表达水平与对照进行比较,其中差异或测试样品和对照之间的一种或多种生物标志物表达水平的相似性用于诊断或预测受试者中OSCC复发的可能性。特别地,本公开描述了使用四基因生物标志物标志的方法和组合物可以预测组织学手术切除切缘正常的受试者口腔鳞状细胞癌的复发。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号